ANDERSON HOAGLAND & CO – Eli Lilly and Company Transaction History
ANDERSON HOAGLAND & CO portfolio value:
$6.69M
portfolio value
ANDERSON HOAGLAND & CO quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.21% | 1.91K shares | 534K | $323.35 | 20.71K |
| Q2 2022 | share | Increase | +47.75% | 6.07K shares | 2.52M | $324.23 | 18.79K |
| Q1 2022 | share | Decrease | -0.89% | -114 shares | 557K | $286.37 | 12.71K |
| Q4 2021 | share | Increase | +1.29% | 163 shares | 158K | $277.25 | 12.83K |
| Q3 2021 | share | Decrease | -0.80% | -102 shares | -4K | $230.3 | 12.66K |
| Q2 2021 | share | Increase | +1.24% | 156 shares | 574K | $228.04 | 12.77K |
| Q1 2021 | share | 0.00% | 0 shares | 227K | $184.81 | 12.61K | |
| Q4 2020 | share | Increase | +78.99% | 5.56K shares | 1.07M | $166.32 | 12.61K |
| Q3 2020 | share | Increase | 0.00% | 7.04K shares | 1.05M | $145.05 | 7.04K |